Tumour regression as a guide to prognosis: a clinical study

Area of Science:

• Oncology
• Radiation Oncology
• Clinical Trials

Background:

• Advanced cervical cancer treatment involves radiotherapy.
• Hyperbaric oxygen has been explored as an adjunct to radiotherapy.
• Assessing early treatment response is crucial for predicting patient outcomes.

Purpose of the Study:

• To evaluate the prognostic value of early tumor response to radiotherapy in advanced cervical cancer.
• To correlate tumor bulk reduction and histological changes with long-term outcomes.
• To assess the impact of hyperbaric oxygen on early response and subsequent prognosis.

Main Methods:

• 116 patients with advanced cervical cancer participated in hyperbaric oxygen trials.
• Radiotherapy was administered in 27 fractions.
• Tumor response was assessed by reduction in bulk and histological examination.
• Patients were followed for 3-13 years for local tumor failure, survival, and metastasis.

Main Results:

• Significant reduction in tumor bulk at the primary site strongly predicted local tumor control, survival, and freedom from metastasis.
• Histological assessment showed a weaker correlation with subsequent clinical course.
• Patients treated with hyperbaric oxygen showed a significantly better immediate response, predicting favorable long-term outcomes.

Conclusions:

• Reduction in primary tumor bulk following radiotherapy is a valuable prognostic index in advanced cervical cancer.
• Early tumor regression is a reliable indicator of treatment efficacy and patient prognosis.
• Hyperbaric oxygen may enhance early treatment response, potentially improving long-term outcomes in cervical cancer radiotherapy.